{"database": "lobbying", "table": "lobbying_activities", "rows": [[864190, "8a973d1e-e3b1-4def-955c-7b2a9956e79c", "4T", "TIMMONS AND COMPANY, INC.", 38164, "TEVA PHARMACEUTICALS USA INC", 2009, "fourth_quarter", "LBR", "H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. \nS. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 1, "2010-01-11T15:46:24.770000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["864190"], "units": {}, "query_ms": 57.55464895628393, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}